NEKTAR THERAPEUTICS
NKTR·640268306·US·Common Stock·Healthcare - Biotechnology-13D/G
NKTR (NEKTAR THERAPEUTICS) is held by 103 institutional investors as of Q1 2026. Largest holders: FMR LLC ($309.6M), VANGUARD CAPITAL MANAGEMENT LLC ($86.1M), TWO SIGMA INVESTMENTS, LP ($67M). Net institutional sentiment: Bullish.
103
Holders
Avg rating(15 Elite)
$1.1B
Total Value
72% (112)
Fund Consensus
75 buying - 29 selling
Who's Trading
ActivistBLBVF PARTNERS L P/IL9.8%May 15, 2026
ActivistTSTwo Seas Capital LP6.8%Apr 17, 2026
InsiderRWROBIN HOWARD WSell $31KFeb 18, 2026
InsiderZJZalevsky JonathanSell $13KFeb 18, 2026
ActivistGEG1 Execution Services, LLC4.0%Feb 13, 2026
InsiderZJZalevsky JonathanSell $138KJan 20, 2026
InsiderRWROBIN HOWARD WSell $120KNov 25, 2025
InsiderWAWilson Mark AndrewSell $34KNov 25, 2025
13F: Insider & Congress:
Showing 1-20 of 112
1 / 6
Continue exploring
Other Healthcare stocks held by institutions
LLYELI LILLY & CO
413 holders · $666.6B
UNHUNITEDHEALTH GROUP INC413 holders · $186.3B
JNJJOHNSON & JOHNSON394 holders · $391.3B
DHRDANAHER CORP DEL392 holders · $97B
ISRGINTUITIVE SURGICAL INC391 holders · $123.5B
TMOTHERMO FISHER SCIENTIFIC INC391 holders · $147B
BSXBOSTON SCIENTIFIC CORP389 holders · $76.8B
MRKMERCK & CO INC385 holders · $208.9B
ABBVABBVIE INC381 holders · $254.9B
ABTABBOTT LABORATORIES380 holders · $129.1B
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer